生命科学资讯

North America Mass Spectrometry Market Report 2025-2033, - GlobeNewswire

North America Mass Spectrometry Market Report 2025-2033, Profiles of Agilent Technologies, Bruker, Danaher, Hitachi, JEOL, LECO, PerkinElmer, and Thermo Fisher Scientific - Yahoo Finance UK

MHRA approves Roche Products’ inavolisib for breast cancer - Pharmaceutical Technology

American Century Companies Inc. Has $75.68 Million Stock Position in Agilent Technologies, Inc. $A - MarketBeat

Is Illumina Inc. stock undervalued vs historical averages - Trend Reversal & Fast Moving Trade Plans - BỘ NỘI VỤ

Helmer Recipient Of First Roche Distinguished Teaching Honor - plaintalk.net

10x Genomics (TXG) Q3 2025 Earnings Transcript - AOL.com

Functional and molecular insights into muscle proprioceptors

The Shigella flexneri effector IpaH1.4 facilitates RNF213 degradation and protects cytosolic bacteria against interferon-induced ubiquitylation

Human RAP2A homolog of the Drosophila asymmetric cell division regulator Rap2l targets the stemness of glioblastoma stem cells

Center-surround inhibition in expectation and its underlying computational and artificial neural network models

The SAFE Labs Handbook as a tool for improving lab culture

Roche jumps in with US bond before Thanksgiving - GlobalCapital

Barbara Roche Obituary (2025) - Marshfield, MA - MacDonald Funeral Home - Marshfield - Legacy | Obituary

FDA Approves Thermo Fisher’s Companion Diagnostic for HER2-Mutated NSCLC Treatment - Lab Manager

Is the Market Bullish or Bearish on Thermo Fisher Scientific Inc? - Benzinga

10x Genomics (TXG) Is Up 19.8% After Pan-Cancer Atlas Collaboration With Garvan and University of Tokyo - simplywall.st

Veeva Systems (VEEV): Evaluating Valuation After Strong Q3 Growth and Expanded Roche Partnership - simplywall.st

Waterloo Capital L.P. Purchases Shares of 2,048 Agilent Technologies, Inc. $A - MarketBeat

Targeted protein degradation in the transmembrane and extracellular space | Science